202 related articles for article (PubMed ID: 15262664)
21. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
[TBL] [Abstract][Full Text] [Related]
22. Cognitive Impairment and Progression of CKD.
Kurella Tamura M; Yaffe K; Hsu CY; Yang J; Sozio S; Fischer M; Chen J; Ojo A; DeLuca J; Xie D; Vittinghoff E; Go AS;
Am J Kidney Dis; 2016 Jul; 68(1):77-83. PubMed ID: 26972681
[TBL] [Abstract][Full Text] [Related]
23. New-onset ESRD secondary to reflux nephropathy has decreased in incidence in the United States.
Cornwell LB; Riddell JV; Mason MD
J Pediatr Urol; 2020 Oct; 16(5):566.e1-566.e7. PubMed ID: 32694090
[TBL] [Abstract][Full Text] [Related]
24. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
[TBL] [Abstract][Full Text] [Related]
25. Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD.
Fung E; Chang TI; Chertow GM; Thomas IC; Asch SM; Kurella Tamura M
Am J Kidney Dis; 2017 Nov; 70(5):705-714. PubMed ID: 28811048
[TBL] [Abstract][Full Text] [Related]
26. Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.
Massie AB; Holscher CM; Henderson ML; Fahmy LM; Thomas AG; Al Ammary F; Getsin SN; Snyder JJ; Lentine KL; Garg AX; Segev DL
JAMA Surg; 2020 Mar; 155(3):e195472. PubMed ID: 31968070
[TBL] [Abstract][Full Text] [Related]
27. The association of exercise and sedentary behaviours with incident end-stage renal disease: the Southern Community Cohort Study.
Pike M; Taylor J; Kabagambe E; Stewart TG; Robinson-Cohen C; Morse J; Akwo E; Abdel-Kader K; Siew ED; Blot WJ; Ikizler TA; Lipworth L
BMJ Open; 2019 Aug; 9(8):e030661. PubMed ID: 31471443
[TBL] [Abstract][Full Text] [Related]
28. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk.
Hallan SI; Coresh J; Astor BC; Asberg A; Powe NR; Romundstad S; Hallan HA; Lydersen S; Holmen J
J Am Soc Nephrol; 2006 Aug; 17(8):2275-84. PubMed ID: 16790511
[TBL] [Abstract][Full Text] [Related]
29. Kidney stones and kidney function loss: a cohort study.
Alexander RT; Hemmelgarn BR; Wiebe N; Bello A; Morgan C; Samuel S; Klarenbach SW; Curhan GC; Tonelli M;
BMJ; 2012 Aug; 345():e5287. PubMed ID: 22936784
[TBL] [Abstract][Full Text] [Related]
30. The association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation Program.
Saab G; Bomback AS; McFarlane SI; Li S; Chen SC; McCullough PA; Whaley-Connell A;
J Clin Endocrinol Metab; 2012 Dec; 97(12):4414-21. PubMed ID: 23066118
[TBL] [Abstract][Full Text] [Related]
31. Lifetime incidence of CKD stages 3-5 in the United States.
Grams ME; Chow EK; Segev DL; Coresh J
Am J Kidney Dis; 2013 Aug; 62(2):245-52. PubMed ID: 23566637
[TBL] [Abstract][Full Text] [Related]
32. Temporal trends in the burden of chronic kidney disease in the United States.
Foley RN
Curr Opin Nephrol Hypertens; 2010 May; 19(3):273-7. PubMed ID: 20164765
[TBL] [Abstract][Full Text] [Related]
33. Chronic renal failure after transplantation of a nonrenal organ.
Ojo AO; Held PJ; Port FK; Wolfe RA; Leichtman AB; Young EW; Arndorfer J; Christensen L; Merion RM
N Engl J Med; 2003 Sep; 349(10):931-40. PubMed ID: 12954741
[TBL] [Abstract][Full Text] [Related]
34. An analysis of hot spots of ESRD in the United States: Potential presence of CKD of unknown origin in the USA?
Bragg-Gresham J; Morgenstern H; Shahinian V; Robinson B; Abbott K; Saran R
Clin Nephrol; 2020; 93(1):113-119. PubMed ID: 31496516
[TBL] [Abstract][Full Text] [Related]
35. Incidence of end-stage renal disease and death among insured African Americans with chronic kidney disease.
Derose SF; Rutkowski MP; Levin NW; Liu IL; Shi JM; Jacobsen SJ; Crooks PW
Kidney Int; 2009 Sep; 76(6):629-37. PubMed ID: 19516247
[TBL] [Abstract][Full Text] [Related]
36. Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis.
Hawkins RG; Houston MC
Am J Hypertens; 2005 Jun; 18(6):744-9. PubMed ID: 15925729
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum anion gap in adults with moderate chronic kidney disease increases risk for progression to end-stage renal disease.
Banerjee T; Crews DC; Wesson DE; McCulloch CE; Johansen KL; Saydah S; Rios Burrows N; Saran R; Gillespie B; Bragg-Gresham J; Powe NR
Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1244-F1253. PubMed ID: 30908932
[TBL] [Abstract][Full Text] [Related]
38. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States.
Patel AR; Dombrovskiy VY; Vogel TR
Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855
[TBL] [Abstract][Full Text] [Related]
39. Is there an epidemic of HIV Infection in the US ESRD program?
Eggers PW; Kimmel PL
J Am Soc Nephrol; 2004 Sep; 15(9):2477-85. PubMed ID: 15339998
[TBL] [Abstract][Full Text] [Related]
40. CKD stage at nephrology referral and factors influencing the risks of ESRD and death.
Sud M; Tangri N; Levin A; Pintilie M; Levey AS; Naimark DM
Am J Kidney Dis; 2014 Jun; 63(6):928-36. PubMed ID: 24485146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
